When: Wednesday 23 August 2023 at 6:30pm AEST
About the Webinar
This webinar provided an overview of RSV disease and an update on approached preventatives – RSV vaccines and new immunoprophylaxis agents. Consideration was given to activities needed to support the introduction of those preventatives, such as programmatic considerations, surveillance, education, and advocacy.
This information will be of interest to healthcare professionals providing care to pregnant women, young children, and older people. In particular, the webinar will be of interest to those healthcare professionals who are involved in the delivery of immunisation services.
Speaker
Dr Gemma Saravanos
Dr Gemma Saravanos is an early career researcher, educator and clinician based at the Susan Wakil School of Nursing and Midwifery, University of Sydney. She also holds a post-doctoral research fellow appointment at the University of Sydney Children’s Hospital Westmead Clinical School. Dr Saravanos has expertise in public health surveillance and epidemiology, infection prevention and control, immunisation and nursing. Her research seeks to better understand the burden of severe acute respiratory infection in different groups and how this can be reduced. A focus of her work has been to understand the epidemiology of respiratory syncytial virus (RSV) in the Australian population to inform future prevention strategies including vaccination.
Moderator
Dr Andrew Minton, PhD
